Reverse logistics in a pharmaceutical company: The Schering case

Ruud H. Teunter, Karl Inderfurth, Stefan Minner, Rainer Kleber

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

6 Scopus citations

Abstract

Schering AG is a pharmaceutical company that was founded in 1871 in Berlin by the pharmacist Ernst Schering. During the past 128 years, Schering has developed into an international pharmaceutical corporation with 145 worldwide subsidiaries and partnerships. In 1998, a staff of 22,043 (44% employed in Germany) contributed to revenues of EUR 2.9 billion. The most important sales regions were the European Union (without Germany) with 28%, North America with 22%, Asia with 15%, Germany with 15%, and Latin America with 10% of the total sales. The largest single market was the U.S.

Original languageEnglish
Title of host publicationManaging Closed-Loop Supply Chains
PublisherSpringer
Pages21-31
Number of pages11
ISBN (Print)3540406980, 9783540406983
DOIs
StatePublished - 2005
Externally publishedYes

Fingerprint

Dive into the research topics of 'Reverse logistics in a pharmaceutical company: The Schering case'. Together they form a unique fingerprint.

Cite this